1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Radioimmunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Non Hodgkin Lymphoma (NHL) 1.2.3 Follicular Lymphoma 1.2.4 Solid Tumors 1.2.5 Breast Cancer 1.2.6 Ovarian Cancer 1.2.7 Osteosarcoma 1.2.8 Neuroblastoma 1.2.9 Prostate Cancer 1.3 Market by Application 1.3.1 Global Radioimmunotherapy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Tumor Antigens 1.3.3 Radionuclides 1.3.4 Antibodies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Radioimmunotherapy Market Perspective (2016-2027) 2.2 Radioimmunotherapy Growth Trends by Regions 2.2.1 Radioimmunotherapy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Radioimmunotherapy Historic Market Share by Regions (2016-2021) 2.2.3 Radioimmunotherapy Forecasted Market Size by Regions (2022-2027) 2.3 Radioimmunotherapy Industry Dynamic 2.3.1 Radioimmunotherapy Market Trends 2.3.2 Radioimmunotherapy Market Drivers 2.3.3 Radioimmunotherapy Market Challenges 2.3.4 Radioimmunotherapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Radioimmunotherapy Players by Revenue 3.1.1 Global Top Radioimmunotherapy Players by Revenue (2016-2021) 3.1.2 Global Radioimmunotherapy Revenue Market Share by Players (2016-2021) 3.2 Global Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Radioimmunotherapy Revenue 3.4 Global Radioimmunotherapy Market Concentration Ratio 3.4.1 Global Radioimmunotherapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Radioimmunotherapy Revenue in 2020 3.5 Radioimmunotherapy Key Players Head office and Area Served 3.6 Key Players Radioimmunotherapy Product Solution and Service 3.7 Date of Enter into Radioimmunotherapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Radioimmunotherapy Breakdown Data by Type 4.1 Global Radioimmunotherapy Historic Market Size by Type (2016-2021) 4.2 Global Radioimmunotherapy Forecasted Market Size by Type (2022-2027) 5 Radioimmunotherapy Breakdown Data by Application 5.1 Global Radioimmunotherapy Historic Market Size by Application (2016-2021) 5.2 Global Radioimmunotherapy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Radioimmunotherapy Market Size (2016-2027) 6.2 North America Radioimmunotherapy Market Size by Type 6.2.1 North America Radioimmunotherapy Market Size by Type (2016-2021) 6.2.2 North America Radioimmunotherapy Market Size by Type (2022-2027) 6.2.3 North America Radioimmunotherapy Market Size by Type (2016-2027) 6.3 North America Radioimmunotherapy Market Size by Application 6.3.1 North America Radioimmunotherapy Market Size by Application (2016-2021) 6.3.2 North America Radioimmunotherapy Market Size by Application (2022-2027) 6.3.3 North America Radioimmunotherapy Market Size by Application (2016-2027) 6.4 North America Radioimmunotherapy Market Size by Country 6.4.1 North America Radioimmunotherapy Market Size by Country (2016-2021) 6.4.2 North America Radioimmunotherapy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Radioimmunotherapy Market Size (2016-2027) 7.2 Europe Radioimmunotherapy Market Size by Type 7.2.1 Europe Radioimmunotherapy Market Size by Type (2016-2021) 7.2.2 Europe Radioimmunotherapy Market Size by Type (2022-2027) 7.2.3 Europe Radioimmunotherapy Market Size by Type (2016-2027) 7.3 Europe Radioimmunotherapy Market Size by Application 7.3.1 Europe Radioimmunotherapy Market Size by Application (2016-2021) 7.3.2 Europe Radioimmunotherapy Market Size by Application (2022-2027) 7.3.3 Europe Radioimmunotherapy Market Size by Application (2016-2027) 7.4 Europe Radioimmunotherapy Market Size by Country 7.4.1 Europe Radioimmunotherapy Market Size by Country (2016-2021) 7.4.2 Europe Radioimmunotherapy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Radioimmunotherapy Market Size (2016-2027) 8.2 Asia-Pacific Radioimmunotherapy Market Size by Type 8.2.1 Asia-Pacific Radioimmunotherapy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Radioimmunotherapy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Radioimmunotherapy Market Size by Type (2016-2027) 8.3 Asia-Pacific Radioimmunotherapy Market Size by Application 8.3.1 Asia-Pacific Radioimmunotherapy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Radioimmunotherapy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Radioimmunotherapy Market Size by Application (2016-2027) 8.4 Asia-Pacific Radioimmunotherapy Market Size by Region 8.4.1 Asia-Pacific Radioimmunotherapy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Radioimmunotherapy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Radioimmunotherapy Market Size (2016-2027) 9.2 Latin America Radioimmunotherapy Market Size by Type 9.2.1 Latin America Radioimmunotherapy Market Size by Type (2016-2021) 9.2.2 Latin America Radioimmunotherapy Market Size by Type (2022-2027) 9.2.3 Latin America Radioimmunotherapy Market Size by Type (2016-2027) 9.3 Latin America Radioimmunotherapy Market Size by Application 9.3.1 Latin America Radioimmunotherapy Market Size by Application (2016-2021) 9.3.2 Latin America Radioimmunotherapy Market Size by Application (2022-2027) 9.3.3 Latin America Radioimmunotherapy Market Size by Application (2016-2027) 9.4 Latin America Radioimmunotherapy Market Size by Country 9.4.1 Latin America Radioimmunotherapy Market Size by Country (2016-2021) 9.4.2 Latin America Radioimmunotherapy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Radioimmunotherapy Market Size (2016-2027) 10.2 Middle East & Africa Radioimmunotherapy Market Size by Type 10.2.1 Middle East & Africa Radioimmunotherapy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Radioimmunotherapy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Radioimmunotherapy Market Size by Type (2016-2027) 10.3 Middle East & Africa Radioimmunotherapy Market Size by Application 10.3.1 Middle East & Africa Radioimmunotherapy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Radioimmunotherapy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Radioimmunotherapy Market Size by Application (2016-2027) 10.4 Middle East & Africa Radioimmunotherapy Market Size by Country 10.4.1 Middle East & Africa Radioimmunotherapy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Radioimmunotherapy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bayer Healthcare Pharmaceuticals 11.1.1 Bayer Healthcare Pharmaceuticals Company Details 11.1.2 Bayer Healthcare Pharmaceuticals Business Overview 11.1.3 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Introduction 11.1.4 Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2016-2021) 11.1.5 Bayer Healthcare Pharmaceuticals Recent Development 11.2 BioSynthema 11.2.1 BioSynthema Company Details 11.2.2 BioSynthema Business Overview 11.2.3 BioSynthema Radioimmunotherapy Introduction 11.2.4 BioSynthema Revenue in Radioimmunotherapy Business (2016-2021) 11.2.5 BioSynthema Recent Development 11.3 Clarity Pharmaceuticals 11.3.1 Clarity Pharmaceuticals Company Details 11.3.2 Clarity Pharmaceuticals Business Overview 11.3.3 Clarity Pharmaceuticals Radioimmunotherapy Introduction 11.3.4 Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2016-2021) 11.3.5 Clarity Pharmaceuticals Recent Development 11.4 Curasight 11.4.1 Curasight Company Details 11.4.2 Curasight Business Overview 11.4.3 Curasight Radioimmunotherapy Introduction 11.4.4 Curasight Revenue in Radioimmunotherapy Business (2016-2021) 11.4.5 Curasight Recent Development 11.5 Endocyte 11.5.1 Endocyte Company Details 11.5.2 Endocyte Business Overview 11.5.3 Endocyte Radioimmunotherapy Introduction 11.5.4 Endocyte Revenue in Radioimmunotherapy Business (2016-2021) 11.5.5 Endocyte Recent Development 11.6 Immunomedics 11.6.1 Immunomedics Company Details 11.6.2 Immunomedics Business Overview 11.6.3 Immunomedics Radioimmunotherapy Introduction 11.6.4 Immunomedics Revenue in Radioimmunotherapy Business (2016-2021) 11.6.5 Immunomedics Recent Development 11.7 Molecular Insight Pharmaceuticals 11.7.1 Molecular Insight Pharmaceuticals Company Details 11.7.2 Molecular Insight Pharmaceuticals Business Overview 11.7.3 Molecular Insight Pharmaceuticals Radioimmunotherapy Introduction 11.7.4 Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2016-2021) 11.7.5 Molecular Insight Pharmaceuticals Recent Development 11.8 Nordic Nanovector 11.8.1 Nordic Nanovector Company Details 11.8.2 Nordic Nanovector Business Overview 11.8.3 Nordic Nanovector Radioimmunotherapy Introduction 11.8.4 Nordic Nanovector Revenue in Radioimmunotherapy Business (2016-2021) 11.8.5 Nordic Nanovector Recent Development 11.9 PDL Biopharma 11.9.1 PDL Biopharma Company Details 11.9.2 PDL Biopharma Business Overview 11.9.3 PDL Biopharma Radioimmunotherapy Introduction 11.9.4 PDL Biopharma Revenue in Radioimmunotherapy Business (2016-2021) 11.9.5 PDL Biopharma Recent Development 11.10 Philogen 11.10.1 Philogen Company Details 11.10.2 Philogen Business Overview 11.10.3 Philogen Radioimmunotherapy Introduction 11.10.4 Philogen Revenue in Radioimmunotherapy Business (2016-2021) 11.10.5 Philogen Recent Development 11.11 RadioMedix 11.11.1 RadioMedix Company Details 11.11.2 RadioMedix Business Overview 11.11.3 RadioMedix Radioimmunotherapy Introduction 11.11.4 RadioMedix Revenue in Radioimmunotherapy Business (2016-2021) 11.11.5 RadioMedix Recent Development 11.12 Stella Pharma 11.12.1 Stella Pharma Company Details 11.12.2 Stella Pharma Business Overview 11.12.3 Stella Pharma Radioimmunotherapy Introduction 11.12.4 Stella Pharma Revenue in Radioimmunotherapy Business (2016-2021) 11.12.5 Stella Pharma Recent Development 11.13 Telix Pharmaceuticals 11.13.1 Telix Pharmaceuticals Company Details 11.13.2 Telix Pharmaceuticals Business Overview 11.13.3 Telix Pharmaceuticals Radioimmunotherapy Introduction 11.13.4 Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2016-2021) 11.13.5 Telix Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Radioimmunotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Non Hodgkin Lymphoma (NHL) Table 3. Key Players of Follicular Lymphoma Table 4. Key Players of Solid Tumors Table 5. Key Players of Breast Cancer Table 6. Key Players of Ovarian Cancer Table 7. Key Players of Osteosarcoma Table 8. Key Players of Neuroblastoma Table 9. Key Players of Prostate Cancer Table 10. Global Radioimmunotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Radioimmunotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Radioimmunotherapy Market Size by Regions (2016-2021) & (US$ Million) Table 13. Global Radioimmunotherapy Market Share by Regions (2016-2021) Table 14. Global Radioimmunotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 15. Global Radioimmunotherapy Market Share by Regions (2022-2027) Table 16. Radioimmunotherapy Market Trends Table 17. Radioimmunotherapy Market Drivers Table 18. Radioimmunotherapy Market Challenges Table 19. Radioimmunotherapy Market Restraints Table 20. Global Radioimmunotherapy Revenue by Players (2016-2021) & (US$ Million) Table 21. Global Radioimmunotherapy Market Share by Players (2016-2021) Table 22. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radioimmunotherapy as of 2020) Table 23. Ranking of Global Top Radioimmunotherapy Companies by Revenue (US$ Million) in 2020 Table 24. Global 5 Largest Players Market Share by Radioimmunotherapy Revenue (CR5 and HHI) & (2016-2021) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Radioimmunotherapy Product Solution and Service Table 27. Date of Enter into Radioimmunotherapy Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Radioimmunotherapy Market Size by Type (2016-2021) (US$ Million) Table 30. Global Radioimmunotherapy Revenue Market Share by Type (2016-2021) Table 31. Global Radioimmunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 32. Global Radioimmunotherapy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 33. Global Radioimmunotherapy Market Size Share by Application (2016-2021) & (US$ Million) Table 34. Global Radioimmunotherapy Revenue Market Share by Application (2016-2021) Table 35. Global Radioimmunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 36. Global Radioimmunotherapy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 37. North America Radioimmunotherapy Market Size by Type (2016-2021) (US$ Million) Table 38. North America Radioimmunotherapy Market Size by Type (2022-2027) & (US$ Million) Table 39. North America Radioimmunotherapy Market Size by Application (2016-2021) (US$ Million) Table 40. North America Radioimmunotherapy Market Size by Application (2022-2027) & (US$ Million) Table 41. North America Radioimmunotherapy Market Size by Country (2016-2021) & (US$ Million) Table 42. North America Radioimmunotherapy Market Size by Country (2022-2027) & (US$ Million) Table 43. Europe Radioimmunotherapy Market Size by Type (2016-2021) (US$ Million) Table 44. Europe Radioimmunotherapy Market Size by Type (2022-2027) & (US$ Million) Table 45. Europe Radioimmunotherapy Market Size by Application (2016-2021) (US$ Million) Table 46. Europe Radioimmunotherapy Market Size by Application (2022-2027) & (US$ Million) Table 47. Europe Radioimmunotherapy Market Size by Country (2016-2021) & (US$ Million) Table 48. Europe Radioimmunotherapy Market Size by Country (2022-2027) & (US$ Million) Table 49. Asia-Pacific Radioimmunotherapy Market Size by Type (2016-2021) (US$ Million) Table 50. Asia-Pacific Radioimmunotherapy Market Size by Type (2022-2027) & (US$ Million) Table 51. Asia-Pacific Radioimmunotherapy Market Size by Application (2016-2021) (US$ Million) Table 52. Asia-Pacific Radioimmunotherapy Market Size by Application (2022-2027) & (US$ Million) Table 53. Asia-Pacific Radioimmunotherapy Market Size by Region (2016-2021) & (US$ Million) Table 54. Asia-Pacific Radioimmunotherapy Market Size by Region (2022-2027) & (US$ Million) Table 55. Latin America Radioimmunotherapy Market Size by Type (2016-2021) (US$ Million) Table 56. Latin America Radioimmunotherapy Market Size by Type (2022-2027) & (US$ Million) Table 57. Latin America Radioimmunotherapy Market Size by Application (2016-2021) (US$ Million) Table 58. Latin America Radioimmunotherapy Market Size by Application (2022-2027) & (US$ Million) Table 59. Latin America Radioimmunotherapy Market Size by Country (2016-2021) & (US$ Million) Table 60. Latin America Radioimmunotherapy Market Size by Country (2022-2027) & (US$ Million) Table 61. Middle East & Africa Radioimmunotherapy Market Size by Type (2016-2021) (US$ Million) Table 62. Middle East & Africa Radioimmunotherapy Market Size by Type (2022-2027) & (US$ Million) Table 63. Middle East & Africa Radioimmunotherapy Market Size by Application (2016-2021) (US$ Million) Table 64. Middle East & Africa Radioimmunotherapy Market Size by Application (2022-2027) & (US$ Million) Table 65. Middle East & Africa Radioimmunotherapy Market Size by Country (2016-2021) & (US$ Million) Table 66. Middle East & Africa Radioimmunotherapy Market Size by Country (2022-2027) & (US$ Million) Table 67. Bayer Healthcare Pharmaceuticals Company Details Table 68. Bayer Healthcare Pharmaceuticals Business Overview Table 69. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Product Table 70. Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 71. Bayer Healthcare Pharmaceuticals Recent Development Table 72. BioSynthema Company Details Table 73. BioSynthema Business Overview Table 74. BioSynthema Radioimmunotherapy Product Table 75. BioSynthema Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 76. BioSynthema Recent Development Table 77. Clarity Pharmaceuticals Company Details Table 78. Clarity Pharmaceuticals Business Overview Table 79. Clarity Pharmaceuticals Radioimmunotherapy Product Table 80. Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 81. Clarity Pharmaceuticals Recent Development Table 82. Curasight Company Details Table 83. Curasight Business Overview Table 84. Curasight Radioimmunotherapy Product Table 85. Curasight Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 86. Curasight Recent Development Table 87. Endocyte Company Details Table 88. Endocyte Business Overview Table 89. Endocyte Radioimmunotherapy Product Table 90. Endocyte Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 91. Endocyte Recent Development Table 92. Immunomedics Company Details Table 93. Immunomedics Business Overview Table 94. Immunomedics Radioimmunotherapy Product Table 95. Immunomedics Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 96. Immunomedics Recent Development Table 97. Molecular Insight Pharmaceuticals Company Details Table 98. Molecular Insight Pharmaceuticals Business Overview Table 99. Molecular Insight Pharmaceuticals Radioimmunotherapy Product Table 100. Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 101. Molecular Insight Pharmaceuticals Recent Development Table 102. Nordic Nanovector Company Details Table 103. Nordic Nanovector Business Overview Table 104. Nordic Nanovector Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 105. Nordic Nanovector Recent Development Table 106. PDL Biopharma Company Details Table 107. PDL Biopharma Business Overview Table 108. PDL Biopharma Radioimmunotherapy Product Table 109. PDL Biopharma Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 110. PDL Biopharma Recent Development Table 111. Philogen Company Details Table 112. Philogen Business Overview Table 113. Philogen Radioimmunotherapy Product Table 114. Philogen Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 115. Philogen Recent Development Table 116. RadioMedix Company Details Table 117. RadioMedix Business Overview Table 118. RadioMedix Radioimmunotherapy Product Table 119. RadioMedix Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 120. RadioMedix Recent Development Table 121. Stella Pharma Company Details Table 122. Stella Pharma Business Overview Table 123. Stella Pharma Radioimmunotherapy Product Table 124. Stella Pharma Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 125. Stella Pharma Recent Development Table 126. Telix Pharmaceuticals Company Details Table 127. Telix Pharmaceuticals Business Overview Table 128. Telix Pharmaceuticals Radioimmunotherapy Product Table 129. Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2016-2021) & (US$ Million) Table 130. Telix Pharmaceuticals Recent Development Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global Radioimmunotherapy Market Share by Type: 2020 VS 2027 Figure 2. Non Hodgkin Lymphoma (NHL) Features Figure 3. Follicular Lymphoma Features Figure 4. Solid Tumors Features Figure 5. Breast Cancer Features Figure 6. Ovarian Cancer Features Figure 7. Osteosarcoma Features Figure 8. Neuroblastoma Features Figure 9. Prostate Cancer Features Figure 10. Global Radioimmunotherapy Market Share by Application: 2020 VS 2027 Figure 11. Tumor Antigens Case Studies Figure 12. Radionuclides Case Studies Figure 13. Antibodies Case Studies Figure 14. Radioimmunotherapy Report Years Considered Figure 15. Global Radioimmunotherapy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 16. Global Radioimmunotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global Radioimmunotherapy Market Share by Regions: 2020 VS 2027 Figure 18. Global Radioimmunotherapy Market Share by Regions (2022-2027) Figure 19. Global Radioimmunotherapy Market Share by Players in 2020 Figure 20. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radioimmunotherapy as of 2020 Figure 21. The Top 10 and 5 Players Market Share by Radioimmunotherapy Revenue in 2020 Figure 22. Global Radioimmunotherapy Revenue Market Share by Type (2016-2021) Figure 23. Global Radioimmunotherapy Revenue Market Share by Type (2022-2027) Figure 24. North America Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. North America Radioimmunotherapy Market Share by Type (2016-2027) Figure 26. North America Radioimmunotherapy Market Share by Application (2016-2027) Figure 27. North America Radioimmunotherapy Market Share by Country (2016-2027) Figure 28. United States Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Canada Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Radioimmunotherapy Market Share by Type (2016-2027) Figure 32. Europe Radioimmunotherapy Market Share by Application (2016-2027) Figure 33. Europe Radioimmunotherapy Market Share by Country (2016-2027) Figure 34. Germany Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. France Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. U.K. Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Italy Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Russia Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Nordic Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Radioimmunotherapy Market Share by Type (2016-2027) Figure 42. Asia-Pacific Radioimmunotherapy Market Share by Application (2016-2027) Figure 43. Asia-Pacific Radioimmunotherapy Market Share by Region (2016-2027) Figure 44. China Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Japan Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. South Korea Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Southeast Asia Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. India Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Australia Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Radioimmunotherapy Market Share by Type (2016-2027) Figure 52. Latin America Radioimmunotherapy Market Share by Application (2016-2027) Figure 53. Latin America Radioimmunotherapy Market Share by Country (2016-2027) Figure 54. Mexico Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Brazil Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Radioimmunotherapy Market Share by Type (2016-2027) Figure 58. Middle East & Africa Radioimmunotherapy Market Share by Application (2016-2027) Figure 59. Middle East & Africa Radioimmunotherapy Market Share by Country (2016-2027) Figure 60. Turkey Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Saudi Arabia Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. UAE Radioimmunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 64. BioSynthema Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 65. Clarity Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 66. Curasight Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 67. Endocyte Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 68. Immunomedics Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 69. Molecular Insight Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 70. Nordic Nanovector Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 71. PDL Biopharma Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 72. Philogen Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 73. RadioMedix Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 74. Stella Pharma Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 75. Telix Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2016-2021) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Bayer Healthcare Pharmaceuticals BioSynthema Clarity Pharmaceuticals Curasight Endocyte Immunomedics Molecular Insight Pharmaceuticals Nordic Nanovector PDL Biopharma Philogen RadioMedix Stella Pharma Telix Pharmaceuticals